Inventor · disambiguated record
Daniel Offen
Also filed as: OFFEN DANIEL
23 granted patents·26 pending applications·131 citations·filing 1999–2023
94Inventor score
Top patents by PatentIndex Score
49 records- 0184US8647874B2Isolated cells and populations comprising same for the treatment of CNS diseasesOFFEN DANIEL·Filed 2007·Granted Feb 11, 2014·5 cites·14 claims
- 0284US6369106B1Treatment of ischemic brain injuries with brain targeted anti oxidant compoundsYISSUM RES DEV CO·Filed 1999·Granted Apr 9, 2002·62 cites·8 claims
- 0383US8900574B2Mesenchymal stem cells for the treatment of CNS diseasesUNIV RAMOT·Filed 2014·Granted Dec 2, 2014·5 cites·4 claims
- 0483US8663987B2Mesenchymal stem cells for the treatment of CNS diseasesKADOURI AVINOAM·Filed 2009·Granted Mar 4, 2014·9 cites·6 claims
- 0582US9474787B2Mesenchymal stem cells for the treatment of CNS diseasesRAMOT AT TEL-AVIV UNIV LTD·Filed 2014·Granted Oct 25, 2016·4 cites·5 claims
- 0676US6420429B1Brain targeted low molecular weight hydrophobic antioxidant compoundsYISSUM RES DEV CO·Filed 1999·Granted Jul 16, 2002·38 cites·8 claims
- 0774US10052363B2Mesenchymal stem cells for the treatment of CNS diseasesUNIV RAMOT·Filed 2016·Granted Aug 21, 2018·1 cites·7 claims
- 0874US9717761B2Stem cell-derived neural cells for cell therapy in neurological disordersRAMOT AT TEL-AVIV UNIV LTD·Filed 2012·Granted Aug 1, 2017·3 cites·10 claims
- 0970US11185572B2Mesenchymal stem cells for the treatment of CNS diseasesUNIV RAMOT·Filed 2018·Granted Nov 30, 2021·0 cites·5 claims
- 1070US8378070B2Peptides for the regulation of neurotransmitter sequestration and releaseUNIV RAMOT·Filed 2008·Granted Feb 19, 2013·0 cites·6 claims
- 1169US11129852B2Mesenchymal cell-derived exosomes to treat neurological disordersUNIV RAMOT·Filed 2017·Granted Sep 28, 2021·1 cites·17 claims
- 1269US9879225B2Isolated cells and populations comprising same for the treatment of CNS diseasesRAMOT AT TEL-AVIV UNIV LTD·Filed 2014·Granted Jan 30, 2018·0 cites·3 claims
- 1368US9598478B2Peptides for the treatment of neurodegenerative diseasesRAMOT AT TEL-AVIV UNIV LTD·Filed 2013·Granted Mar 21, 2017·1 cites·10 claims
- 1467US9023800B2Peptides for the treatment of oxidative stress related disordersOFFEN DANIEL·Filed 2012·Granted May 5, 2015·1 cites·2 claims
- 1567US8212001B2Peptides for the treatment of oxidative stress related disordersOFFEN DANIEL·Filed 2010·Granted Jul 3, 2012·1 cites·5 claims
- 1666US10869899B2Isolated cells and populations comprising same for the treatment of CNS diseasesUNIV RAMOT·Filed 2017·Granted Dec 22, 2020·0 cites·10 claims
- 1765US10744162B2Genetically modified muscle cells which express neurotrophic factorsRAMOT AT TEL-AVIV UNIV LTD·Filed 2019·Granted Aug 18, 2020·0 cites·4 claims
- 1864US2023330130A1Vesicles comprising a pten inhibitor and uses of sameTECHNION RES & DEV FOUNDATION·Filed 2023·Application pending·0 cites
- 1963US11648260B2Vesicles comprising a PTEN inhibitor and uses of sameTECHNION RES & DEV FOUNDATION·Filed 2019·Granted May 16, 2023·0 cites·8 claims
- 2062US2024398839A1Cannabinoid-lipid conjugates, methods for producing the same and uses thereofUNIV RAMOT·Filed 2022·Application pending·0 cites
- 2161US2024245720A1Compositions comprising extracellular vesicles and an active agent and uses thereofUNIV RAMOT·Filed 2022·Application pending·0 cites
- 2258US10723706B2Perk inhibitors and uses thereof in treating diseases associated with aggregation-prone proteinsUNIV RAMOT·Filed 2017·Granted Jul 28, 2020·0 cites·12 claims
- 2357US2020149063A1Methods for gender determination and selection of avian embryos in unhatched eggsEGGXYT LTD·Filed 2019·Application pending·0 cites
- 2457US2021361717A1Mesenchymal cell-derived exosomes to treat neurological disordersUNIV RAMOT·Filed 2021·Application pending·0 cites
- 2556US2022251153A1Peptides for the treatment of renal disordersUNIV GEORGE WASHINGTON·Filed 2022·Application pending·0 cites
- 2654US11104651B2PERK inhibitors and uses thereof in treating diseases associated with aggregation-prone proteinsUNIV RAMOT·Filed 2020·Granted Aug 31, 2021·0 cites·20 claims
- 2754US2025215407A1Improved macromolecules and methods for designing sameUNIV RAMOT·Filed 2023·Application pending·0 cites
- 2854US2009257987A1Method of generating dopamine-secreting cellsUNIV RAMOT·Filed 2009·Application pending·0 cites
- 2954US2023115463A1Cannabidiol-containing compositions and uses thereofUNIV RAMOT·Filed 2022·Application pending·0 cites
- 3054US2002107176A1Brain targeted low molecular weight hydrophobic anti oxidant compoundsFiled 2002·Application pending·0 cites
- 3153US2013236964A1Methods, nucleic acid constructs and cells for treating neurodegenerative disordersUNIV RAMOT·Filed 2013·Application pending·0 cites
- 3251US9365828B2Genetically modified muscle cells which express neurotrophic factorsOFFEN DANIEL·Filed 2012·Granted Jun 14, 2016·0 cites·2 claims
- 3351US2003083266A1Treatment of ischemic brain injuries with brain targeted antioxidant compoundsFiled 2000·Application pending·0 cites
- 3449US2016279169A1Genetically modified muscle cells which express neurotrophic factorsRAMOT AT TEL-AVIV UNIV LTD·Filed 2016·Application pending·0 cites
- 3549US2019029236A1Methods for gender determination of avian embryos in unhatched eggs and means thereofEGGXYT LTD·Filed 2018·Application pending·0 cites
- 3648US2010021434A1Isolated Oligodendrocyte-Like Cells and Populations Comprising Same for the Treatment of CNS DiseasesUNIV RAMOT·Filed 2006·Application pending·0 cites
- 3747US10040836B2Peptides for the treatment of neurodegenerative diseasesUNIV RAMOT·Filed 2017·Granted Aug 7, 2018·0 cites·9 claims
- 3847US2021214699A1Methods and compositions for modulating myeloperoxidase (mpo) expressionLEMPO THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 3947US2006211628A1Treatment of multiple sclerosis with brain targeted anti oxidant compoundsATLAS DAPHNE·Filed 2003·Application pending·0 cites
- 4046US2013123187A1Peptides for the regulation of neurotransmitter sequestration and releaseUNIV RAMOT·Filed 2012·Application pending·0 cites
- 4146US2020283849A1Methods for gender determination of avian embryos in unhatched eggs and means thereofEGGXYT LTD·Filed 2018·Application pending·0 cites
- 4245US2004235747A1Methods of treating and/or preventing autoimmune diseasesUNIV RAMOT·Filed 2003·Application pending·0 cites
- 4344US2005265983A1Methods, nucleic acid constructs and cells for treating neurodegenerative disordersMELAMED ELDAD·Filed 2005·Application pending·0 cites
- 4443US2020009180A1Methods of treating alzheimer's diseaseUNIV RAMOT·Filed 2018·Application pending·0 cites
- 4540US2021121539A1Methods and compositions for modulating myeloperoxidase (mpo) expressionLEMPO THERAPEUTICS LTD·Filed 2019·Application pending·0 cites
- 4639US10220077B2Combination treatment for amyotrophic lateral sclerosis (ALS)OFFEN DANIEL·Filed 2013·Granted Mar 5, 2019·0 cites·6 claims
- 4739US2020370040A1Treatment for parkinsonian patients with mutations in the lrrk2 geneUNIV RAMOT·Filed 2018·Application pending·0 cites
- 4838US2018008648A1Scaffold-seeded oral mucosa stem cellsRAMOT AT TEL-AVIV UNIV LTD·Filed 2016·Application pending·0 cites
- 4936US2015284793A1Methods and kits for diagnosing schizophreniaUNIV RAMOT·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Daniel Offen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →